Physiologically based pharmacokinetic –pharmacodynamic modeling to predict concentrations and actions of sodium‐dependent glucose transporter 2 inhibitor canagliflozin in human intestines and renal tubules

This article is protected by copyright. All rights reserved.

Source: Biopharmaceutics and Drug Disposition - August 31, 2016 Category: Drugs & Pharmacology Authors: Kazumi Mori, Ryuta Saito, Yoshinobu Nakamaru, Makiko Shimizu, Hiroshi Yamazaki Tags: Original Paper Source Type: research